261 related articles for article (PubMed ID: 18798555)
1. Identification of an invasion and tumor-suppressing gene, Endoglin (ENG), silenced by both epigenetic inactivation and allelic loss in esophageal squamous cell carcinoma.
Wong VC; Chan PL; Bernabeu C; Law S; Wang LD; Li JL; Tsao SW; Srivastava G; Lung ML
Int J Cancer; 2008 Dec; 123(12):2816-23. PubMed ID: 18798555
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of the novel tumor suppressor DIRAS1 predicts poor prognosis in esophageal squamous cell carcinoma.
Zhu YH; Fu L; Chen L; Qin YR; Liu H; Xie F; Zeng T; Dong SS; Li J; Li Y; Dai Y; Xie D; Guan XY
Cancer Res; 2013 Apr; 73(7):2298-309. PubMed ID: 23436800
[TBL] [Abstract][Full Text] [Related]
3. Endoglin promoter hypermethylation identifies a field defect in human primary esophageal cancer.
Jin Z; Zhao Z; Cheng Y; Dong M; Zhang X; Wang L; Fan X; Feng X; Mori Y; Meltzer SJ
Cancer; 2013 Oct; 119(20):3604-9. PubMed ID: 23893879
[TBL] [Abstract][Full Text] [Related]
4. Monochromosome transfer and microarray analysis identify a critical tumor-suppressive region mapping to chromosome 13q14 and THSD1 in esophageal carcinoma.
Ko JM; Chan PL; Yau WL; Chan HK; Chan KC; Yu ZY; Kwong FM; Miller LD; Liu ET; Yang LC; Lo PH; Stanbridge EJ; Tang JC; Srivastava G; Tsao SW; Law S; Lung ML
Mol Cancer Res; 2008 Apr; 6(4):592-603. PubMed ID: 18403638
[TBL] [Abstract][Full Text] [Related]
5. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
Tanaka K; Imoto I; Inoue J; Kozaki K; Tsuda H; Shimada Y; Aiko S; Yoshizumi Y; Iwai T; Kawano T; Inazawa J
Oncogene; 2007 Sep; 26(44):6456-68. PubMed ID: 17438526
[TBL] [Abstract][Full Text] [Related]
6. Tumor suppressive role of a 2.4 Mb 9q33-q34 critical region and DEC1 in esophageal squamous cell carcinoma.
Yang L; Leung AC; Ko JM; Lo PH; Tang JC; Srivastava G; Oshimura M; Stanbridge EJ; Daigo Y; Nakamura Y; Tang CM; Lau KW; Law S; Lung ML
Oncogene; 2005 Jan; 24(4):697-705. PubMed ID: 15580306
[TBL] [Abstract][Full Text] [Related]
7. Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma.
Ma S; Bao JYJ; Kwan PS; Chan YP; Tong CM; Fu L; Zhang N; Tong AHY; Qin YR; Tsao SW; Chan KW; Lok S; Guan XY
Gastroenterology; 2012 Sep; 143(3):675-686.e12. PubMed ID: 22705009
[TBL] [Abstract][Full Text] [Related]
8. Frequent decreased expression of candidate tumor suppressor gene, DEC1, and its anchorage-independent growth properties and impact on global gene expression in esophageal carcinoma.
Leung AC; Wong VC; Yang LC; Chan PL; Daigo Y; Nakamura Y; Qi RZ; Miller LD; Liu ET; Wang LD; Li JL; Law S; Tsao SW; Lung ML
Int J Cancer; 2008 Feb; 122(3):587-94. PubMed ID: 17943723
[TBL] [Abstract][Full Text] [Related]
9. Characterization of tumor suppressive function of P300/CBP-associated factor at frequently deleted region 3p24 in esophageal squamous cell carcinoma.
Zhu C; Qin YR; Xie D; Chua DT; Fung JM; Chen L; Fu L; Hu L; Guan XY
Oncogene; 2009 Aug; 28(31):2821-8. PubMed ID: 19525977
[TBL] [Abstract][Full Text] [Related]
10. [Allelic loss and down-regulation of FHIT gene expression in esophageal squamous cell carcinoma].
Liu FX; Huang XP; Zhao CX; Xu X; Han YL; Cai Y; Wu RL; Wu M; Zhan QM; Wang MR
Ai Zheng; 2004 Sep; 23(9):992-8. PubMed ID: 15363189
[TBL] [Abstract][Full Text] [Related]
11. Involvement of TSLC1 in progression of esophageal squamous cell carcinoma.
Ito T; Shimada Y; Hashimoto Y; Kaganoi J; Kan T; Watanabe G; Murakami Y; Imamura M
Cancer Res; 2003 Oct; 63(19):6320-6. PubMed ID: 14559819
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic silencing of HIC1 promotes epithelial-mesenchymal transition and drives progression in esophageal squamous cell carcinoma.
Li P; Liu X; Dong ZM; Ling ZQ
Oncotarget; 2015 Nov; 6(35):38151-65. PubMed ID: 26510908
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic inactivation of secreted frizzled-related protein 2 in esophageal squamous cell carcinoma.
Hao XW; Zhu ST; He YL; Li P; Wang YJ; Zhang ST
World J Gastroenterol; 2012 Feb; 18(6):532-40. PubMed ID: 22363119
[TBL] [Abstract][Full Text] [Related]
14. Frequent silencing of protocadherin 17, a candidate tumour suppressor for esophageal squamous cell carcinoma.
Haruki S; Imoto I; Kozaki K; Matsui T; Kawachi H; Komatsu S; Muramatsu T; Shimada Y; Kawano T; Inazawa J
Carcinogenesis; 2010 Jun; 31(6):1027-36. PubMed ID: 20200074
[TBL] [Abstract][Full Text] [Related]
15. High Expression of GRP78 Promotes Invasion and Metastases in Patients with Esophageal Squamous Cell Carcinoma.
Zhao G; Kang J; Jiao K; Xu G; Yang L; Tang S; Zhang H; Wang Y; Nie Y; Wu K; Fan D; Zhang H; Zhang D
Dig Dis Sci; 2015 Sep; 60(9):2690-9. PubMed ID: 25976624
[TBL] [Abstract][Full Text] [Related]
16. Loss of CRNN expression is associated with advanced tumor stage and poor survival in patients with esophageal squamous cell carcinoma.
Hsu PK; Kao HL; Chen HY; Yen CC; Wu YC; Hsu WH; Chou TY
J Thorac Cardiovasc Surg; 2014 May; 147(5):1612-1618.e4. PubMed ID: 24263008
[TBL] [Abstract][Full Text] [Related]
17. RASSF1A gene promoter methylation in esophageal cancer specimens.
Yamaguchi S; Kato H; Miyazaki T; Sohda M; Kimura H; Ide M; Asao T; Kuwano H
Dis Esophagus; 2005; 18(4):253-6. PubMed ID: 16128782
[TBL] [Abstract][Full Text] [Related]
18. Loss of CDCP1 expression promotes invasiveness and poor prognosis in esophageal squamous cell carcinoma.
Sawada G; Takahashi Y; Niida A; Shimamura T; Kurashige J; Matsumura T; Ueo H; Uchi R; Takano Y; Ueda M; Hirata H; Sakimura S; Shinden Y; Eguchi H; Sudo T; Sugimachi K; Miyano S; Doki Y; Mori M; Mimori K
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S640-7. PubMed ID: 24849519
[TBL] [Abstract][Full Text] [Related]
19. Identification of GPX3 epigenetically silenced by CpG methylation in human esophageal squamous cell carcinoma.
He Y; Wang Y; Li P; Zhu S; Wang J; Zhang S
Dig Dis Sci; 2011 Mar; 56(3):681-8. PubMed ID: 20725785
[TBL] [Abstract][Full Text] [Related]
20. Tumor suppressor dual-specificity phosphatase 6 (DUSP6) impairs cell invasion and epithelial-mesenchymal transition (EMT)-associated phenotype.
Wong VC; Chen H; Ko JM; Chan KW; Chan YP; Law S; Chua D; Kwong DL; Lung HL; Srivastava G; Tang JC; Tsao SW; Zabarovsky ER; Stanbridge EJ; Lung ML
Int J Cancer; 2012 Jan; 130(1):83-95. PubMed ID: 21387288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
